• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与 C3 p.Ile1157Thr 基因突变相关的复发性非典型溶血尿毒综合征导致的肾损伤。

Renal Damage in Recurrent Atypical Hemolytic Uremic Syndrome Associated with C3 p.Ile1157Thr Gene Mutation.

机构信息

Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Japan.

出版信息

Intern Med. 2021 Mar 15;60(6):917-922. doi: 10.2169/internalmedicine.5716-20. Epub 2020 Oct 21.

DOI:10.2169/internalmedicine.5716-20
PMID:33087669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8024950/
Abstract

Patients with atypical hemolytic uremic syndrome (aHUS) associated with a C3 p.Ile1157Thr mutation show a relatively high renal survival and low mortality rates, but renal histopathological findings after recurrence have been rarely reported. A 30-year-old man with a C3 p.Ile1157Thr mutation experienced a third recurrence of thrombotic microangiopathies with neurological and gastrointestinal disorders. A renal biopsy performed during the recovery phase of acute kidney injury revealed collapsed glomeruli and arteriolar vacuolization. Approximately 10% of glomeruli were globally sclerotic, despite the absence of arterio-/arteriolo-sclerosis. These findings suggest substantial progression of irreversible injuries in multiple organs, including kidneys, which occurs in aHUS patients with repeated thrombotic microangiopathies.

摘要

携 C3 p.Ile1157Thr 突变的非典型溶血尿毒综合征(aHUS)患者的肾脏存活率相对较高,死亡率较低,但复发后的肾脏组织病理学发现却很少有报道。一位 30 岁的男性携 C3 p.Ile1157Thr 突变,经历了第三次血栓性微血管病伴神经和胃肠道紊乱的复发。在急性肾损伤的恢复期进行的肾脏活检显示肾小球塌陷和小动脉空泡化。尽管没有动脉/小动脉硬化,约 10%的肾小球呈全球性硬化。这些发现提示包括肾脏在内的多个器官的不可逆损伤实质性进展,这发生在反复发生血栓性微血管病的 aHUS 患者中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe04/8024950/17971780d14e/1349-7235-60-0917-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe04/8024950/92798dcd2bcd/1349-7235-60-0917-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe04/8024950/17971780d14e/1349-7235-60-0917-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe04/8024950/92798dcd2bcd/1349-7235-60-0917-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe04/8024950/17971780d14e/1349-7235-60-0917-g002.jpg

相似文献

1
Renal Damage in Recurrent Atypical Hemolytic Uremic Syndrome Associated with C3 p.Ile1157Thr Gene Mutation.与 C3 p.Ile1157Thr 基因突变相关的复发性非典型溶血尿毒综合征导致的肾损伤。
Intern Med. 2021 Mar 15;60(6):917-922. doi: 10.2169/internalmedicine.5716-20. Epub 2020 Oct 21.
2
aHUS associated with C3 gene mutation: a case with numerous relapses and favorable 20-year outcome.与C3基因突变相关的非典型溶血尿毒综合征:一例多次复发且20年预后良好的病例
Pediatr Nephrol. 2016 Mar;31(3):513-7. doi: 10.1007/s00467-015-3267-3. Epub 2015 Nov 16.
3
Pathology of renal diseases associated with dysfunction of the alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS).与补体替代途径功能障碍相关的肾脏疾病的病理学:C3 肾小球病和非典型溶血尿毒综合征 (aHUS)。
Semin Thromb Hemost. 2014 Jun;40(4):416-21. doi: 10.1055/s-0034-1375701. Epub 2014 May 5.
4
Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.活体供肾移植治疗非典型溶血尿毒综合征:病例系列研究。
Am J Kidney Dis. 2017 Dec;70(6):770-777. doi: 10.1053/j.ajkd.2017.06.024. Epub 2017 Aug 16.
5
Complement Factor I Gene Variant in an Atypical Hemolytic Uremic Syndrome Triggered by Hypereosinophilia Syndrome.补体因子 I 基因变异在嗜酸性粒细胞增多综合征引发的非典型溶血尿毒综合征中的作用。
Nephron. 2023;147(11):701-706. doi: 10.1159/000531879. Epub 2023 Aug 23.
6
Atypical hemolytic-uremic syndrome: recurrent phenotypic expression of a patient with MCP gene mutation combined with risk haplotypes.非典型溶血尿毒综合征:一名伴有风险单倍型的MCP基因突变患者的复发表型表达
Blood Coagul Fibrinolysis. 2019 Mar;30(2):68-70. doi: 10.1097/MBC.0000000000000793.
7
Atypical Hemolytic Uremic Syndrome Presenting as Acute Heart Failure-A Rare Presentation: Diagnosis Supported by Skin Biopsy.表现为急性心力衰竭的非典型溶血性尿毒症综合征——一种罕见表现:皮肤活检支持诊断
J Investig Med High Impact Case Rep. 2019 Jan-Dec;7:2324709619842905. doi: 10.1177/2324709619842905.
8
Atypical haemolytic uraemic syndrome: a case of rare genetic mutation.非典型溶血尿毒综合征:一例罕见基因突变病例。
BMJ Case Rep. 2021 Jul 30;14(7):e244190. doi: 10.1136/bcr-2021-244190.
9
Thrombotic microangiopathy: focus on atypical hemolytic uremic syndrome.血栓性微血管病:聚焦非典型溶血性尿毒症综合征
Hematol Oncol Clin North Am. 2015 Jun;29(3):541-59. doi: 10.1016/j.hoc.2015.02.002. Epub 2015 Apr 4.
10
[Recurrent atypical hemolytic uremic syndrome after renal transplantation: treatment with eculizumab].[肾移植后复发性非典型溶血尿毒综合征:依库珠单抗治疗]
Medicina (B Aires). 2018;78(2):119-122.

引用本文的文献

1
Atypical hemolytic uremic syndrome with a variant following COVID-19: a case report.新型冠状病毒肺炎后出现变异型的非典型溶血性尿毒症综合征:一例报告
Front Pediatr. 2025 Jan 23;13:1507727. doi: 10.3389/fped.2025.1507727. eCollection 2025.
2
Eculizumab for paediatric patients with atypical haemolytic uraemic syndrome: full dataset analysis of post-marketing surveillance in Japan.依库珠单抗治疗小儿非典型溶血尿毒综合征:日本上市后监测的全数据集分析。
Nephrol Dial Transplant. 2023 Feb 13;38(2):414-424. doi: 10.1093/ndt/gfac150.

本文引用的文献

1
Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation.肾移植中钙调神经磷酸酶和雷帕霉素哺乳动物靶蛋白抑制剂的病理学
Kidney Int Rep. 2017 Oct 27;3(2):281-290. doi: 10.1016/j.ekir.2017.10.010. eCollection 2018 Mar.
2
Extra-renal manifestations of atypical hemolytic uremic syndrome.非肾性表现的非典型溶血尿毒综合征。
Pediatr Nephrol. 2019 Aug;34(8):1337-1348. doi: 10.1007/s00467-018-4039-7. Epub 2018 Aug 14.
3
Clinical Manifestation of Patients With Atypical Hemolytic Uremic Syndrome With the C3 p.I1157T Variation in the Kinki Region of Japan.
日本近畿地区携带C3 p.I1157T变异的非典型溶血尿毒综合征患者的临床表现
Clin Appl Thromb Hemost. 2018 Nov;24(8):1301-1307. doi: 10.1177/1076029618771750. Epub 2018 Apr 25.
4
Extra-Renal manifestations of atypical hemolytic uremic syndrome in children.儿童非典型溶血尿毒综合征的肾外表现。
Pediatr Nephrol. 2018 Aug;33(8):1395-1403. doi: 10.1007/s00467-018-3933-3. Epub 2018 Apr 2.
5
Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome.日本非典型溶血性尿毒症综合征患者的临床特征及遗传背景
Clin Exp Nephrol. 2018 Oct;22(5):1088-1099. doi: 10.1007/s10157-018-1549-3. Epub 2018 Mar 6.
6
Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.罕见补体变异的统计学验证为非典型溶血尿毒症综合征和 C3 肾小球病的分子基础提供了新见解。
J Immunol. 2018 Apr 1;200(7):2464-2478. doi: 10.4049/jimmunol.1701695. Epub 2018 Mar 2.
7
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.非典型溶血尿毒综合征与 C3 肾小球病:“改善全球肾脏病预后组织”(KDIGO)争议会议的结论。
Kidney Int. 2017 Mar;91(3):539-551. doi: 10.1016/j.kint.2016.10.005. Epub 2016 Dec 16.
8
Disease Recurrence After Early Discontinuation of Eculizumab in a Patient With Atypical Hemolytic Uremic Syndrome With Complement C3 I1157T Mutation.一例伴有补体C3 I1157T突变的非典型溶血性尿毒症综合征患者早期停用依库珠单抗后的疾病复发
J Pediatr Hematol Oncol. 2016 Apr;38(3):e137-9. doi: 10.1097/MPH.0000000000000505.
9
A novel quantitative hemolytic assay coupled with restriction fragment length polymorphisms analysis enabled early diagnosis of atypical hemolytic uremic syndrome and identified unique predisposing mutations in Japan.一种新型定量溶血测定法与限制性片段长度多态性分析相结合,能够早期诊断非典型溶血尿毒症综合征,并在日本发现了独特的易感突变。
PLoS One. 2015 May 7;10(5):e0124655. doi: 10.1371/journal.pone.0124655. eCollection 2015.
10
Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome.利用非典型溶血性尿毒症综合征中的突变来绘制补体C3与调节因子之间的相互作用。
Blood. 2015 Apr 9;125(15):2359-69. doi: 10.1182/blood-2014-10-609073. Epub 2015 Jan 21.